FX Shoulder Solutions, Inc. appears in FDA device records as an applicant for shoulder arthroplasty devices under product codes tied to reverse shoulder prostheses. The supplied collection holds one linked 510(k) record, K260417 for the Easytech Reversed Shoulder System, with a substantially equivalent decision dated November 5, 2026. A separate FDA letter addresses K254154 for the FX V135 EASYTECH Shoulder System. Company descriptions published by FX Solutions describe a shoulder-only arthroplasty focus and the Easytech stemless reverse line. [1][3][5]
Documented FDA submissions
K260417 covers the Easytech Reversed Shoulder System, received February 9, 2026 and decided November 5, 2026 as substantially equivalent under a traditional clearance path. The record lists product code PHX, regulation number 888.3660, device class 2, and the openFDA device name Shoulder Prosthesis, Reverse Configuration, with the orthopedic advisory committee. The applicant address on the filing is 15920 Addison Rd., Suite 200, Addison, Texas. [1]
An FDA letter dated May 1, 2026 concerns K254154, trade name FX V135 EASYTECH Shoulder System, under regulation 21 CFR 888.3660, class II, with product codes PKC, PHX, KWT and HSD. The letter describes the device as a shoulder replacement system that may be used as a total shoulder replacement in either an anatomic or a reversed shoulder construct. [3]
Product features as published
FX Solutions publishes the Easytech Reversed as a 145° neck shaft angle primary reverse stemless prosthesis. The publisher states the peripheral pegs are designed for immediate primary fixation, with plasma sprayed CP titanium and hydroxyapatite coating intended to promote long term fixation. The same page lists a cementless anchor base in three sizes from 30mm to 38mm and two glenosphere sizes, 36 and 40mm. [4]
The company's own about page states that FX has focused only on shoulder arthroplasty and has been active in the shoulder arthroplasty market since 2011, describing the Humelock I fracture system and the Easytech stemless reverse shoulder replacement among its products. These are company-published characterizations rather than FDA findings. [5]
Applicant identity and scope
The FDA records identify FX Shoulder Solutions, Inc. as the applicant, and the K254154 letter is addressed to a named regulatory contact at the Addison, Texas address. That address is a filing address; the sources do not establish a corporate headquarters, ownership structure or parent company. [1][3]
The supplied collection contains one linked 510(k) record with a substantially equivalent decision, and the sample of one record carries the same single decision. These counts describe the supplied filings as of the snapshot date and are not measures of total portfolio, sales or safety performance. No recall records appear in the supplied collection. [1]

